Akari Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.85-$4.40
Market Cap
$30.3M
Shares Short
77,707

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$2.58

News

See more

Yahoo Finance • 8 days ago

Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer

Yahoo Finance • 2 months ago

Akari Therapeutics Joins Webull Corporate Connect Service Platform

Yahoo Finance • last year

Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference

Yahoo Finance • last year

Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference

About

CEO
Dr. Samir Rashmikant Patel M.D.
Address
22 Boston Wharf Road, Boston, MA, United States, 02210
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
9